Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bioware (often stylized as BioWare or Bio-Ware) was a specialized biotechnology company focused on the development of bioluminescent cell lines and imaging technologies for preclinical research. The company's core technology involved the engineering of tumor cell lines and microorganisms to express luciferase, allowing researchers to monitor disease progression and therapeutic efficacy in real-time within living models. This non-invasive imaging platform significantly advanced the fields of oncology and infectious disease research by providing more accurate and longitudinal data. Bioware's assets were eventually integrated into larger life science tool providers, where they continue to be a standard in the industry for in vivo optical imaging.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioWare.